Lung Deposition of the Dry Powder Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Using NEXThaler ® Device in Healthy Subjects, Asthmatic Patients, and COPD Patients - Virchow, Johann Christian; Poli, Gianluigi; Herpich, Christiane; Kietzig, Claudius; Ehlich, Hilke; Braeutigam, Daniela; Sommerer, Knut; Häussermann, Sabine; Mariotti, Fabrizia (Journal of aerosol medicine, 2018)
Keywords: Administration, Inhalation; Adult; Aged; Airway management; Asthma; Asthma - drug therapy; Beclomethasone - administration & dosage; Beclomethasone - adverse effects; Beclomethasone - pharmacokinetics; Chlorofluorocarbons; Chronic obstructive pulmonary disease; Drug Combinations; Drug dosages; Dry Powder Inhalers; Formoterol; Formoterol Fumarate - administration & dosage; Formoterol Fumarate - adverse effects; Formoterol Fumarate - pharmacokinetics; Healthy Volunteers; Humans; Inhalation; Inhalers; Lung - metabolism; Lung diseases; Middle Aged; Original Research; Particle size; Patients; Pharmacodynamics; Powder; Pulmonary Disease, Chronic Obstructive - drug therapy; Reproducibility of Results; Respiratory function; Respiratory therapy; Scintigraphy; Italy; Germany; NEXThaler® DPI; asthma; inhaled drug; lung deposition; BDP/formoterol combination; COPD